ApprovalTrail

Company · Pointe-Claire, Quebec, Canada

Pharma Stulln Inc.

Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.

Drug products (DIN)
28
24 authorized now
Natural health products
2
2 active licences
Medical device licences
0
0 active
Notices of Compliance
2

Drug products

Authorized products first.

NameDINStatus
ATROPINE02023695Marketed
DEXAMETHASONE02023865Marketed
DICLOFENAC02475065Marketed
ERYTHROMYCIN02141574Marketed
BALANCED SALT SOLUTION02023709Dormant
CHLORAMPHENICOL02023857Dormant
DIOPTICON A LIQ02026465Dormant
DIOPTICON LIQ 0.1%02026546Dormant
DIOPTROL SUSPENSION02023806Dormant
DIOROUGE LIQ02026511Dormant
FLUORESCEIN02027089Dormant
LIDOCAINE02510057Approved
OPTILUBE PVA LIQ 1.4%02026481Dormant
PHENYLEPHRINE02027100Dormant
PHENYLEPHRINE/HYDROXYETHYLCELLULOSE02026473Dormant
PILOCARPINE02023741Dormant
PILOCARPINE02023725Dormant
PILOCARPINE02023733Dormant
POLYSORBATE02026538Dormant
PREDNISOLONE/SULFACETAMIDE02023814Dormant
PROPARACAINE02023652Dormant
SULFACETAMIDE02023830Dormant
TROPICAMIDE02023679Dormant
TROPICAMIDE02023660Dormant
CYCLOPENTOLATE02023644Cancelled Post Market
CYCLOPENTOLATE02023687Cancelled Post Market
FLUORESCEIN02027097Cancelled Post Market
GENTAMICIN02023822Cancelled Post Market

Natural health products

Active licences first, newest first.

NameNPNStatus
BSS-STULLN80131058Active
Saline Stulln80127042Active

Notices of Compliance

Newest first.

  • DICLOFENACNovember 21, 2023 · NOC 32152 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • DICLOFENACJune 19, 2018 · NOC 21001 · Abbreviated New Drug Submission (ANDS)